CLOT RETREIVAL SYSTEM  
UCLA Technology Available For Licensing

Researchers at UCLA have developed a novel system, device and method for the mechanical extraction of a thrombus (clot) from within an arterial or venous vessel. This invention will significantly increase the number of patients positively responding to thrombectomy while decreasing the potential for vessel wall disruption that accompanies the current procedure and device.

BACKGROUND:  Stroke is the third leading cause of death in the US, following heart disease and cancer, and the leading cause of adult disability. Because of the devastation and financial burden that stroke outcomes can have on patients, their families, and the health care infrastructure, there is a strong need to create newer and more effective acute stroke interventions to decrease the substantial mortality rates associated with current treatments. For acute ischemic stroke, which makes up approximately 80% of stroke diagnoses, thrombectomy (mechanical retrieval of the clot), with or without IV recombinant tissue plasminogen activator (rt-PA), has been shown to be the most efficacious course of treatment in the acute stroke setting. Although a few devices have been developed, only the MERCI system (UCLA) has been properly established to date. However, this system is not without difficulties: Only half of the patients with vessel occlusion can be recanalized with this device.

INNOVATION:  Using the invaluable lessons learned from the MERCI device trials, researchers at UCLA have created a system, device and method that allows for the mechanical extraction of a clot from an arterial or venous vessel that improves upon the current thrombectomy treatments available in both safety and efficacy.

POTENTIAL APPLICATIONS 

ADVANTAGES

DEVELOPMENT-TO-DATE: Device is currently in the conceptual stage.

Related Papers (Selected)

Reference: UCLA Case No. 2008-034

For additional technical details and current licensing
availability, please contact the following UCLA office:

UCLA Office of Intellectual Property
11000 Kinross Avenue, Suite #200
Los Angeles, CA 90095
Tel: 310-794-0558 Fax: 310-794-0638
email: ncd@research.ucla.edu
NCD URL:   http://www.research.ucla.edu/tech/ucla08-034.htm

Lead Inventor: Yince Loh

UCLA Technologies Available for Licensing
http://www.research.ucla.edu/oipa/industry

Copyright © 2008 The Regents of the University of California.

keywords: acute ischemic stroke, thrombus, embolus, thrombolysis, thrombectomy, intervention, clot, retrieval, thrombolysis, recombinant tissue plasminogen activator, rt-PA, biomedical, devices, process/procedure, therapeutic uclancd ucla latest inventions technology top ten 10 technologies intellectual property patents technology transfer invention business card